Mei Pharma rebrands to Lite Strategy, prioritizing litecoin

MEI Pharma has officially rebranded itself as Lite Strategy, emphasizing Litecoin as its primary treasury asset. This marks a historic first for a U.S.-listed company.

Charlie Lee, Litecoin’s creator, will join Lite Strategy’s board, bringing expertise and credibility. The company is investing over 100 million USD, demonstrating commitment to this new digital asset focus.

As of September 10, 2025, Litecoin (LTC) trades at 115.07 USD, with a market cap of approximately 8.78 billion USD, showing a 2.75% increase in the last 24 hours.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts